AptarGroup Division Says It Gets US FDA 510K Clearance for HeroTracker Sense as Class 2 Medical Device

MT Newswires Live
2025/10/16

AptarGroup's (ATR) Aptar Digital Health division said Thursday that its HeroTracker Sense has received the US Food and Drug Administration's 510k clearance as a Class 2 medical device.

HeroTracker Sense is compatible with multiple asthma and chronic obstructive pulmonary disease medicines, and helps patients oversee their respiratory health through medication and symptom management, Aptar Digital said.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10